THE Malaysian Organisation of Pharmaceutical Industries (MOPI) has called for help in the opening up of new markets for Malaysian ma- nufactured pharmaceutical products through an emphasis on PIC/S (Pharmaceutical In- spection Convention and Pharmaceutical In- spection Cooperation Scheme) compliance as well as to adopt a more stringent attitude towards importers of products from non-PIC/S countries.
MOPI said in its memorandum that in spite of having invested heavily in meeting PIC/S requirements and the accompanying higher standards, it had failed to gain significant international recognition while imports from non-PIC/S countries had continued, leading to an erosion in the market share of MOPI members.